DealsSerán Bioscience snags investment from Bain Capital Life SciencesSerán's existing investor Vivo Capital remains a key shareholder in the company.ByIris Dorbian17 September 2024•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsNorth AmericaUSHealthcareBriefs